{
    "nct_id": "NCT06639958",
    "official_title": "Risk-Based 6MP Adherence Enhancement Strategies in Children, Adolescent and Young Adults With ALL - A Pilot Study",
    "inclusion_criteria": "* Age: >= 10 years and =< 25 years\n* Previously enrolled onto AALL1732\n* Consented to the AALL1732 mercaptopurine adherence correlative study\n* Maintenance therapy has not yet begun\n* English or Spanish-speaking (patient and parent/other adult)\n* Planning to receive 6MP (as tablets) during maintenance phase of therapy\n* Able and willing to use the MEMSÂ® TrackCapâ„¢ (e.g., not using a pillbox or prescribed liquid 6MP)\n* Has a designated parent/other adult who is willing to enter into a mutual agreement with the patient to participate in a daily supervised medication administration routine\n* Patient/parent/other adult must be willing to use a smartphone to receive medication reminders\n* Receiving treatment at a Children's Oncology Group (COG) institution in the United States\nHealthy volunteers allowed\nMust have minimum age of 10 Years\nMust have maximum age of 25 Years",
    "exclusion_criteria": "* Patients who have previously participated in or are currently participating in another intervention clinical trial designed to improve adherence\n* Regulatory requirements\n\n  * All patients and/or their parents or legal guardians must sign a written informed consent\n  * All institutional, Food and Drug Administration (FDA), and National Cancer Institute (NCI) requirements for human studies must be met",
    "miscellaneous_criteria": ""
}